C

Clearside Biomedical
D

CLSD

0.48880
USD
-0.05
(-9.30%)
مغلق
حجم التداول
11,604
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
37,983,932
أصول ذات صلة
C
CRSP
-1.350
(-2.04%)
64.760 USD
C
CRVS
-0.05500
(-1.16%)
4.70000 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
N
NTLA
0.830
(6.50%)
13.595 USD
R
RGNX
-0.17000
(-1.86%)
8.96000 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
V
VCEL
0.410
(1.03%)
40.160 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.